There are a handful of reasons: 1) Obesity : 1 in 8 is obese worldwide, doubled since 1990 2) Usage : increasing into apnea, kidney and heart health, in testing for cancer & addiction 3) Ease : pills will bring down costs and increase usage 4) Innovation : new drugs bring greater weight loss, fewer side effects and unique action 5) Cost : pills, generics, subsidies, insurance and increased competitors all drive price down Q: Is GLP-1 a trend that is likely to stay or is the bubble about to burst
Front Physiol 2019;10:413
That said, compounded semaglutide is far from the only affordable alternative to brand-name semaglutide
Thats why its a strong new choice for fighting obesity
Mechanistically, studies indicate that the transition from hyperoxia back to normoxia paradoxically suppresses FAO while promoting ceramide synthesis, both pathways converging to promote apoptosis